AbbVie | ABBV - Trade Debtors

Stock Price
197.69
Daily Change
0.31 0.16%
Monthly
-7.24%
Yearly
2.16%
Q2 Forecast
194.46

AbbVie reported $12.77B in Trade Debtors for its fiscal quarter ending in September of 2025.





Trade Debtors Change Date
AbbVie USD 12.77B 132M Sep/2025
Abbott USD 10.57B 171M Dec/2025
ALKERMES USD 334.02M 21.08M Dec/2025
Amgen USD 9.57B 1.08B Dec/2025
AstraZeneca USD 19.05B 1.49B Dec/2025
Biogen USD 1.85B 234M Sep/2025
BioMarin Pharmaceutical USD 908.21M 117.95M Dec/2025
Bristol-Myers Squibb USD 14.62B 485M Sep/2025
Coherus Biosciences USD 18.42M 232.08M Dec/2025
Eisai JPY 249.06B 25B Dec/2025
Eli Lilly USD 19.46B 2.25B Sep/2025
Gilead Sciences USD 4.91B 182M Dec/2025
GlaxoSmithKline GBP 7.76B 545M Dec/2025
J&J USD 21.33B 3.72B Dec/2025
Medtronic USD 6.36B 30M Dec/2025
Merck USD 12.12B 596M Sep/2025
Neurocrine Biosciences USD 686.8M 41.2M Dec/2025
Novartis USD 12.29B 3.3B Dec/2025
Pacira USD 124.07M 8.8M Dec/2025
Perrigo USD 612.8M 31.6M Dec/2025
Pfizer USD 18.12B 2.02B Sep/2025
Regeneron Pharmaceuticals USD 5.74B 54M Dec/2025
Roche Holding CHF 11.9B 460M Dec/2025
Sanofi EUR 482M 85M Mar/2026
UCB EUR 1.97B 54M Dec/2025
Ultragenyx Pharmaceutical USD 112.54M 11.92M Sep/2025
United Therapeutics USD 350.2M 52.5M Dec/2025
Vertex Pharmaceuticals USD 2.05B 106.4M Dec/2025
Zoetis USD 1.59B 49M Dec/2025